Krebs Biochemicals & Industries Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Krebs Biochemicals & Industries Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
27.41% Fall from 52W High
-8.3
TTM PE Ratio
Negative PE TTM
-7.1
Price to Book Ratio
Negative Price to Book
-1.5
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-0.2
RSI
RSI is mid-range
46.5
MFI
MFI is mid-range
50.5

Krebs Biochemicals & Industries Ltd shareholding Pattern

Promoter
72.7%
Foreign Institutions
0.5%
Public
26.8%
Promoter
72.7%
Foreign Institutions
0.5%
Public
26.8%
Promoter
72.7%
Foreign Institutions
0.5%
Public
26.8%
Promoter
72.7%
Foreign Institutions
0.5%
Public
26.8%
Promoter
72.7%
Foreign Institutions
0.5%
Public
26.8%
Promoter
72.7%
Foreign Institutions
0.3%
Public
27%

Krebs Biochemicals & Industries Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
3
Bearish Moving Averages
13
5Day EMA
67.60
10Day EMA
68.30
12Day EMA
68.60
20Day EMA
69.20
26Day EMA
69.40
50Day EMA
70.20
100Day EMA
71.50
200Day EMA
74.10
5Day SMA
67.40
10Day SMA
68.00
20Day SMA
70.30
30Day SMA
70.70
50Day SMA
69.10
100Day SMA
72.40
150Day SMA
74.20
200Day SMA
73.00
Delivery & Volume
Resistance & Support
67.90
Pivot
Resistance
First Resistance
68.80
Second Resistance
69.40
Third Resistance
70.30
Support
First Support
67.30
Second support
66.40
Third Support
65.80
Relative Strength Index
46.47
Money Flow Index
50.54
MACD
-0.90
MACD Signal
-0.46
Average True Range
3.53
Average Directional Index
16.55
Rate of Change (21)
-7.02
Rate of Change (125)
-17.78
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Bal Pharma Ltd.
162.64
80.6
132.2
Mangalam Drugs and Organics Ltd.
159.31
85.16
132.4
Aarey Drugs & Pharmaceuticals Ltd.
131.85
27.65
68
Auro Laboratories Ltd.
-
-
-
Vaishali Pharma Ltd.
-
-
-
Sotac Pharmaceuticals Ltd
-
-
-

Krebs Biochemicals & Industries Ltd Company background

Founded in: 1991
Managing director: Jitendra Shah
Krebs Biochemicals Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same.Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry. Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies.KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 200102, the company launched Vitamin C(I P Grade) through Fermentation Process. The Company commissioned 2.5 MW Cogeneration Power Plant at Unit II in Vizag during 200304 and started operations on it from July, 2004 onwards.
Read More

Krebs Biochemicals & Industries Ltd FAQs

The past 1-year return of Krebs Biochemicals & Industries Ltd [KREBSBIO] share was 0.75. The Krebs Biochemicals & Industries Ltd [KREBSBIO] share hit a 1-year low of Rs. 59.3 and a 1-year high of Rs. 93.2.

You can easily buy Krebs Biochemicals & Industries Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage